Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qiao-Min Hua"'
Autor:
Dan-Ni Zeng, Chong Wu, Chun-Xia Huang, Qiao-Min Hua, Jin-Zhu Li, Weiping Wen, Limin Zheng, Yan Wu, Jing Xu, Jing Liao
Publikováno v:
Molecular Therapy. 30:632-643
Macrophages constitute a major component in human hepatocellular carcinoma (HCC) and perform various functions to facilitate disease progression. Reprogramming or reconstituting the tumor surveillance phenotypes of macrophages represents an attractiv
Autor:
Jing, Liao, Dan-Ni, Zeng, Jin-Zhu, Li, Qiao-Min, Hua, Chun-Xia, Huang, Jing, Xu, Chong, Wu, Limin, Zheng, Wei-Ping, Wen, Yan, Wu
Publikováno v:
Mol Ther
Macrophages constitute a major component in human hepatocellular carcinoma (HCC) and perform various functions to facilitate disease progression. Reprogramming or reconstituting the tumor surveillance phenotypes of macrophages represents an attractiv
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Myeloid cells are key components of the tumor microenvironment and critical regulators of disease progression. These innate immune cells are usually short-lived and require constant replenishment. Emerging evidence indicates that tumors alter the hos
Autor:
Jinqing Li, Cheng Sun, Yulan Weng, Dan-Ni Zeng, Mingyu Liu, Qiao-Min Hua, Jin-Hua Huang, Minshan Chen, Zhenhong Guo, Shufeng Luo, Li Xu, Jian Zhou, Shi-Mei Zhuang, Jing Liao, Chong Wu, Jie Lin, Chao Liu, Limin Zheng, Chao-Qun Liu, Jing Xu
Publikováno v:
J Clin Invest
BACKGROUND: Despite an increasing appreciation of the roles that myeloid cells play in tumor progression and therapy, challenges remain in interpreting the tumor-associated myeloid response balance and its translational value. We aimed to construct a
Autor:
Zhiyu Xiao, Jing Liao, Wei-Ping Wen, Limin Zheng, Chuanchao He, Jin-Zhu Li, Yifan Chu, Dan-Ni Zeng, Qiao-Min Hua, Kai Mao, Yan Wu, Ling-Yan Zhu
Publikováno v:
Hepatology international. 14(1)
Sorafenib is the most widely used first-line treatment for patients with advanced hepatocellular carcinoma (HCC), but such treatment provides only limited survival benefits that might be related to the immune status of distinct tumor microenvironment